At the news
? NEUTRALIMPACT 3/10 8-K filed Nov 4, 2026 at 16:10 ET
Monro extended its shareholder rights plan (poison pill) by one year, from November 6, 2026 to November 1, 2027, to support an ongoing review of strategic alternatives. The extension preserves the board's ability to conduct the review without the risk of an unsolicited takeover.
- Rights Agreement final expiration extended from November 6, 2026 to November 1, 2027.
- Extension approved by Board to support ongoing review of strategic alternatives.
- Rights are redeemable at $0.01 per Right at the Company's option.
- Purchase price per one one-thousandth of a share of Preferred Stock is $90.00.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access